$RBRK

Nithrakashyap Arvind sold $3.0M of RBRK

Nithrakashyap Arvind (Chief Technology Officer) sold 38,460 shares of Rubrik, Inc. (RBRK) at an average of $79.19 ($73.72–$84.61, $3.05M total) across 11 trades over 2026-08-03 to 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Nithrakashyap Arvind
Published Aug 5, 2026, 11:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBRK
Neutral
medium confidence
Mentioned
$RBRK
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBRKNeutralLow
01

Why it matters

The key new information is the disclosed sale size ($3.05M) and the fact it was executed under a pre-arranged 10b5-1 plan, which generally lowers the interpretive weight for near-term fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure suggests the event is more informational than catalytic.

03

What to watch

The article does not disclose whether other insiders sold/bought around the same time, nor does it provide post-sale performance or guidance changes, limiting inference.

Relevance 5/10Novelty 5/10Timing: filed Aug 5, covering sales executed Aug 3-5

Background

This is an SEC Form 4 insider transaction for Rubrik, Inc., reported by its CTO and executed across 11 trades over Aug 3-5.

Company-level read

Ticker impact

$RBRKNeutralMedium confidence
Context

Rubrik CTO Nithrakashyap Arvind sold about $3.05M of RBRK shares in an open-market sale under a 10b5-1 plan from Aug 3-5.

Expected impact

Likely limited immediate impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is a primary Form 4 disclosure with a defined sale window and stated pre-arranged 10b5-1 plan, which typically dampens interpretive value for price direction.

Market effects

Minimal, as this is company-specific insider activity without any sector-wide regulatory or demand signal.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, so traders may overreact if they treat it as a discretionary sell.

Key entities

  • Rubrik, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Nithrakashyap Arvind

    Rubrik CTO who sold shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RBRKMed

Here's How Rubrik Stock Gained 28.6% Last Month

Rubrik (RBRK) rose 28.6% in August 2026, driven by a cybersecurity rally and strong earnings. Q2 2027 earnings showed a profit of $0.20 per share and 41% revenue growth. The stock trades at 12.7x sales and 68x free cash flow, with analysts calling the post-earnings drop a buying opportunity. The company's growth and market position make it appealing despite its high valuation and volatility.

$RBRKMed

Jim Cramer on Rubrik (RBRK): “It Just Came in Maybe Too Hot”

Rubrik, Inc. (RBRK) reported Q2 fiscal 2027 revenue of $427.3M, up 38% YoY, beating estimates. EPS was $0.20, above consensus. Subscription ARR rose 33% to $1.66B. Guidance was raised. Despite strong results, shares dropped 13% post-earnings, possibly due to high expectations. Free cash flow grew 14% YoY, but margins declined. Hedge fund holdings decreased slightly, and short interest is around 9%.

$RBRKMed

Rubrik’s AI Security Bet Could Power the Next Leg Higher

Rubrik reported Q2 earnings with adjusted EPS of $0.20, beating estimates by $0.16. Revenue and earnings guidance exceeded expectations. Analysts raised price targets, with a consensus near pre-release highs. Institutional investors have been accumulating shares. Risks include high valuation and competition, notably from Microsoft. The company expects GAAP profitability by 2028.